Vivo Bio Tech Ltd511509Corporate

Biotechnology Latest results: Jun 2026 13 quarters of data

₹16.85

MCap ₹37 Cr

Vivo Bio Tech Ltd — Stock analysis & AI research Vivo Bio Tech Ltd — Live exchange announcements

AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.

₹14 Cr

Sales · Jun 2026

+14.1% YoY

₹5 Cr

Operating Profit · Jun 2026

-7.8% YoY

35.4%

OPM % · Jun 2026

-19.2% YoY

₹0 Cr

Net Profit · Jun 2026

-86.0% YoY

₹0.08

EPS · Jun 2026

-88.1% YoY

📝 Vivo Bio Tech Ltd — results explained

Quarter ended June 2026 (Q1 FY27)

Vivo Bio Tech Ltd reported revenue of ₹14 crore for the quarter ended June 2026 (Q1 FY27), up 14.1% from ₹13 crore in the same quarter last year, and up 0.6% sequentially over the March 2026 quarter.

Net profit fell 86.0% year-on-year to ₹0 crore, from ₹1 crore. Earnings per share (EPS) came in at ₹0.08.

Operating profit stood at ₹5 crore — an operating margin (OPM) of 35.4%, compared with 43.8% in the year-ago quarter.

Full year and trailing twelve months

For the full year FY26, Vivo Bio Tech Ltd posted revenue of ₹53 crore, a growth of 14.3% over FY25, with a net loss of ₹2 crore.

On a trailing-twelve-month (TTM) basis, revenue stands at ₹55 crore with a net loss of ₹3 crore.

Valuation snapshot

At the current price of ₹16.85, 511509 has a market capitalisation of ₹37 crore.

Within the Biotechnology industry, it is the 6th-largest of the 8 companies we track by market value.

Shareholding pattern

As of Mar 2026, promoters held 35.43%, public shareholders 64.58% of Vivo Bio Tech Ltd.

Promoter holding rose from 35.17% to 35.43% over the latest period.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close

Valuation

Market Cap ?

₹37 Cr

Current Price ?

₹16.9

P/E ?

N/A

Industry P/E ?

106.70

P/B ?

0.40

P/S ?

0.68

P/FCF ?

-9.32

Enterprise Value ?

₹105 Cr

EV/EBITDA ?

5.13

PEG ?

N/A

Earnings Yield ?

8.5%

Dividend Yield ?

0.00%

Profitability & Returns

Sales (TTM) ?

₹55 Cr

OPM ?

37.0%

Profit after tax (TTM) ?

₹-3 Cr

EPS (TTM) ?

₹-1.29

ROCE ?

7.3%

ROE ?

-3.1%

ROA ?

-1.6%

Growth

Sales — latest qtr ?

₹14 Cr

PAT — latest qtr ?

₹0 Cr

YoY qtr sales growth ?

14.1%

YoY qtr profit growth ?

-86.0%

Sales growth (3y) ?

Sales growth (5y) ?

Profit growth (3y) ?

N/A

Profit growth (5y) ?

N/A

Financial Health

Debt ?

₹67 Cr

Debt to Equity ?

0.72

Interest Coverage ?

1.7

Current Ratio ?

N/A

Ownership

Promoter holding ?

35.43%

Change in promoter holding ?

-3.64%

Pledged percentage ?

N/A

Market

Return 3 months ?

-29.9%

Return 6 months ?

-35.0%

🗓️ Quarterly results (13 quarters · ₹ Cr)

same fiscal quarter as Jun bestweakest per row · for costs (interest, NPAs) low is best Highlight

Metric	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	YoY %	QoQ %
Sales	12	9	13	12	10	12	12	12	13	13	14	14	14	+14.1%	+0.6%
Operating Profit	4	5	6	5	4	6	6	5	5	5	5	4	5	-7.8%	+13.5%
Other Income	0	0	0	0	0	5	0	0	0	0	0	0	0	-60.4%	+84.7%
Interest	2	2	2	2	2	2	2	2	2	1	1	1	1	-17.5%	-16.4%
Depreciation	2	2	2	2	2	2	2	2	3	3	3	3	4	+33.8%	+28.4%
Profit Before Tax	0	0	2	1	0	6	1	1	1	2	2	0	0	-77.1%	+35.4%
Net Profit	0	0	1	1	0	5	1	1	1	1	1	-5	0	-86.0%	+103.6%
EPS	0.09	0.22	0.89	0.50	0.11	3.51	0.51	0.62	0.67	0.39	0.57	-2.33	0.08	-88.1%	+103.4%
OPM %	38.8%	52.5%	49.6%	45.7%	43.0%	46.4%	45.4%	40.8%	43.8%	41.3%	40.6%	31.3%	35.4%	-19.2%	+13.1%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric	FY25	FY26	TTM	YoY %
Sales	₹47 Cr	₹53 Cr	₹55 Cr	+14.3%
Operating Profit	₹21 Cr	₹21 Cr	₹20 Cr	+1.6%
OPM %	43.95%	39.08%	37.05%	-11.1%
NPM %	15.60%	-3.19%	-5.18%	-120.4%
Other Income	₹5 Cr	₹0 Cr	₹0 Cr	-90.8%
Depreciation	₹9 Cr	₹11 Cr	₹12 Cr	+17.7%
Interest	₹8 Cr	₹6 Cr	₹6 Cr	-22.0%
EBIT	₹11 Cr	₹10 Cr	₹9 Cr	-11.1%
PBT	₹9 Cr	₹5 Cr	₹4 Cr	-45.3%
Tax	—	—	₹0 Cr	—
Net Profit	₹7 Cr	₹-2 Cr	₹-3 Cr	-123.4%
EPS	₹4.75	₹-0.70	₹-1.29	-114.7%
Material Cost	—	—	₹3 Cr	—
Employee Cost	—	—	₹5 Cr	—
Extraordinary Items	—	—	—	—

🏛️ Balance Sheet (latest 4 periods)

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	% Chg
Equity Capital	14.90	14.90	17.16	22.19	+29.3%
Reserves	36.97	39.50	60.74	70.97	+16.8%
Borrowings	62.39	73.06	54.03	67.38	+24.7%
Other Liabilities	8.77	9.67	11.30	17.89	+58.3%
Total Liabilities	123.03	137.13	143.23	178.43	+24.6%
Fixed Assets	88.87	80.37	88.24	123.02	+39.4%
CWIP	1.90	9.21	12.84	4.81	-62.5%
Investments	0.00	0.00	0.00	21.91	—
Other Assets	32.26	47.55	42.15	28.69	-31.9%
Total Assets	123.03	137.13	143.23	178.43	+24.6%

💧 Cash Flow (latest 4 periods)

Metric	Mar 2022	Mar 2023	Mar 2024	Mar 2025	% Chg
Cash from Operating Activity	16.64	14.83	15.52	11.83	-23.8%
Cash from Investing Activity	-51.11	-4.00	-7.95	-15.84	-99.2%
Cash from Financing Activity	35.02	-11.18	-7.56	3.90	+151.6%
Net Cash Flow	0.55	-0.34	0.01	-0.11	-1200.0%
Free Cash Flow	-34.47	10.83	7.57	-4.01	-153.0%
CFO/OP	118%	77%	80%	65%	-18.8%

➗ Ratios (latest 4 periods)

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	% Chg
Debtor Days	86.52	94.76	87.98	80.42	-8.6%
Inventory Days	429.70	831.44	491.08	365.90	-25.5%
Days Payable	50.68	100.49	61.78	88.00	+42.4%
Cash Conversion Cycle	465.53	825.71	517.29	358.32	-30.7%
Working Capital Days	38.09	63.76	100.26	-22.24	-122.2%
ROCE %	11.02%	9.94%	9.04%	7.29%	-19.4%

👥 Shareholding (latest 4 periods)

Metric	Jun 2025	Sep 2025	Dec 2025	Mar 2026	% Chg
Promoters	39.07%	35.17%	35.17%	35.43%	+0.7%
Public	60.94%	64.84%	64.84%	64.58%	-0.4%
No. of Shareholders	21,865	21,647	21,622	21,427	-0.9%

⚖️ Peer comparison

Industry: Biotechnology · 8 companies · full page →

#	Company	CMP	MCap (Cr)	P/E	Sales TTM	NP TTM	OPM%	NPM%	Sales YoY%	NP YoY%	Qtr Rev Δ%	Qtr NP Δ%
1	BIOCON Biocon	₹390.65	63,609	147.4	17,322	417	20.4%	2.4%	10.9%	-74.2%	10.0%	53.4%
2	ANTHEM ANTHEM BIOSCIENCES	₹874.85	49,142	85.4	2,002	576	39.6%	28.8%	—	—	-22.6%	-11.7%
3	ONESOURCE ONESOURCE SPECL	₹1,592.00	18,256	—	1,544	-49	21.9%	-3.2%	-1.6%	-185.0%	37.3%	0.7%
4	CONCORDBIO Concord Biotech	₹1,510.00	15,797	57.6	1,109	273	34.9%	24.6%	-12.1%	-30.4%	26.2%	31.0%
5	514336 CCME Global	₹15.10	150	—	0	-1	-2079.0%	-2135.5%	-98.9%	-120.3%	—	-120.2%
6	511509 Vivo Bio	₹37.69	37	—	55	-3	37.0%	-5.2%	14.3%	-123.4%	14.1%	-86.0%
7	539470 Shree Ganesh	₹1.20	18	—	5	-0	-35.3%	-7.8%	-78.4%	34.2%	3.6%	-273.7%
8	539206 Genomic Valley	₹52.00	9	n/m	0	0	11.7%	6.7%	-68.2%	-94.4%	-57.8%	-26.9%

❓ Frequently asked questions

What was Vivo Bio Tech Ltd's revenue in Q1 FY27?

What was Vivo Bio Tech Ltd's net profit in Q1 FY27?